Vasodilating Mechanisms of Levosimendan: Involvement of K+ Channels
Levosimendan, a novel agent developed for the treatment of acute and decompensated heart failure, exerts potent positive inotropic action and peripheral vasodilatory effects. The mechanism of vasodilation by levosimendan may involve reduction of Ca2+ sensitivity of contractile proteins in vascular s...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2007-01-01
|
| Series: | Journal of Pharmacological Sciences |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319342720 |
| _version_ | 1828383379845808128 |
|---|---|
| author | Oguzhan Yildiz |
| author_facet | Oguzhan Yildiz |
| author_sort | Oguzhan Yildiz |
| collection | DOAJ |
| description | Levosimendan, a novel agent developed for the treatment of acute and decompensated heart failure, exerts potent positive inotropic action and peripheral vasodilatory effects. The mechanism of vasodilation by levosimendan may involve reduction of Ca2+ sensitivity of contractile proteins in vascular smooth muscle, the lowering of intracellular free Ca2+, the potential inhibition of phosphodiesterase (PDE) III, and an opening of K+ channels. Although the importance and relative contribution of each of these mechanisms of vasorelaxation is unclear and may be different in various vessels and dependent on the dose of levosimendan, the important roles of K+-channel opening and Ca2+ desensitization in vascular smooth muscle are obvious, whereas the role of PDE inhibition remains to be defined. This review article briefly discusses the current research data on the mechanism of levosimendan-induced vasodilation with an emphasis on the types of the blood vessels and the K+ channels. It also summarizes the current experimental and clinical knowledge of the use of levosimedan in the treatment of heart failure. Keywords:: levosimendan, vasodilation, mechanism of action, K+ channel, Ca2+ desensitization |
| first_indexed | 2024-12-10T04:47:23Z |
| format | Article |
| id | doaj.art-cc9d968d91c54240851acd4dc5645ed4 |
| institution | Directory Open Access Journal |
| issn | 1347-8613 |
| language | English |
| last_indexed | 2024-12-10T04:47:23Z |
| publishDate | 2007-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Pharmacological Sciences |
| spelling | doaj.art-cc9d968d91c54240851acd4dc5645ed42022-12-22T02:01:42ZengElsevierJournal of Pharmacological Sciences1347-86132007-01-01104115Vasodilating Mechanisms of Levosimendan: Involvement of K+ ChannelsOguzhan Yildiz0Department of Pharmacology, Gulhane School of Medicine, 06018 Ankara, Turkey; Corresponding author. oyildiz@gata.edu.trLevosimendan, a novel agent developed for the treatment of acute and decompensated heart failure, exerts potent positive inotropic action and peripheral vasodilatory effects. The mechanism of vasodilation by levosimendan may involve reduction of Ca2+ sensitivity of contractile proteins in vascular smooth muscle, the lowering of intracellular free Ca2+, the potential inhibition of phosphodiesterase (PDE) III, and an opening of K+ channels. Although the importance and relative contribution of each of these mechanisms of vasorelaxation is unclear and may be different in various vessels and dependent on the dose of levosimendan, the important roles of K+-channel opening and Ca2+ desensitization in vascular smooth muscle are obvious, whereas the role of PDE inhibition remains to be defined. This review article briefly discusses the current research data on the mechanism of levosimendan-induced vasodilation with an emphasis on the types of the blood vessels and the K+ channels. It also summarizes the current experimental and clinical knowledge of the use of levosimedan in the treatment of heart failure. Keywords:: levosimendan, vasodilation, mechanism of action, K+ channel, Ca2+ desensitizationhttp://www.sciencedirect.com/science/article/pii/S1347861319342720 |
| spellingShingle | Oguzhan Yildiz Vasodilating Mechanisms of Levosimendan: Involvement of K+ Channels Journal of Pharmacological Sciences |
| title | Vasodilating Mechanisms of Levosimendan: Involvement of K+ Channels |
| title_full | Vasodilating Mechanisms of Levosimendan: Involvement of K+ Channels |
| title_fullStr | Vasodilating Mechanisms of Levosimendan: Involvement of K+ Channels |
| title_full_unstemmed | Vasodilating Mechanisms of Levosimendan: Involvement of K+ Channels |
| title_short | Vasodilating Mechanisms of Levosimendan: Involvement of K+ Channels |
| title_sort | vasodilating mechanisms of levosimendan involvement of k channels |
| url | http://www.sciencedirect.com/science/article/pii/S1347861319342720 |
| work_keys_str_mv | AT oguzhanyildiz vasodilatingmechanismsoflevosimendaninvolvementofkchannels |